1297PImmune-related adverse events (irAEs) with single-agent PD-1 vs PD-L1 inhibitors: A meta-analysis of 8,730 patients from clinical trials
Sonpavde, G P, Grivas, P, Lin, Y, Hennessy, D, Hunt, J DVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz253.122
Date:
October, 2019
File:
PDF, 81 KB
2019